Skip to main content

Pathologic Assessment and Specimen Quality of Surgery After CME

  • Chapter
  • First Online:
Surgical Treatment of Colorectal Cancer

Abstract

Quality of surgery has recently become an important topic in the management of colon cancer. Both en bloc resection and resection of an adequate area of colon and mesocolon are mandatory for high-quality surgery. The quality of surgery is assessed by pathologic evaluation, including morphologic assessment of the plane of dissection, length of colon resected, length of the high tie vascular ligation of the mesenteric artery to the colon, and the number of lymph nodes studied. Morphologic assessment is a qualitative measure of the plane of dissection, and smooth dissection could contribute to good prognosis. The other measures are quantitative and reflect the area of colon and mesocolon resected. Adequate resection area could not only lead to a good prognosis but also enable accurate staging in colon cancer. In this section, we discuss the relationship between quality of surgery and pathologic assessment, highlighting the difference between D3 dissection in Asian countries and complete mesocolic excision (CME) in Western countries. Precise estimation of tumor depth is also considered critical for predicting prognosis in colon cancer. In particular, it is crucial to discriminate a T4 lesion from a T3 lesion, because the former is a potential risk factor for recurrence of disease. However, accurate diagnosis is difficult. We introduce our method of pathologic examination for differentiating these lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. den Dulk M, van de Velde CJ. Time to focus on the quality of colon-cancer surgery. Lancet Oncol. 2008;9:815–7.

    Article  Google Scholar 

  2. Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol. 2012;17:1–29.

    Article  PubMed  Google Scholar 

  3. Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome. Color Dis. 2009;11:354–64.

    Article  CAS  Google Scholar 

  4. West NP, Hohenberger W, Weber K, Perrakis A, Finan PJ, Quirke P. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol. 2010;28:272–8.

    Article  PubMed  Google Scholar 

  5. Bertelsen CA, Bols B, Ingeholm P, Jansen JE, Neuenschwander AU, Vilandt J. Can the quality of colonic surgery be improved by standardization of surgical technique with complete mesocolic excision? Color Dis. 2011;13:1123–9.

    Article  CAS  Google Scholar 

  6. Quirke P, West N. Quality of surgery: has the time come for colon cancer? Lancet Oncol. 2015;16:121–2.

    Article  PubMed  Google Scholar 

  7. West NP, Morris EJ, Rotimi O, Cairns A, Finan PJ, Quirke P. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol. 2008;9:857–65.

    Article  PubMed  Google Scholar 

  8. Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005;365:1718–26.

    Article  PubMed  Google Scholar 

  9. Kobayashi H, West NP, Takahashi K, Perrakis A, Weber K, Hohenberger W, et al. Quality of surgery for stage III colon cancer: comparison between England, Germany, and Japan. Ann Surg Oncol. 2014;21(Suppl 3):S398–404.

    Article  PubMed  Google Scholar 

  10. Culligan K, Sehgal R, Mulligan D, Dunne C, Walsh S, Quondamatteo F, et al. A detailed appraisal of mesocolic lymphangiology--an immunohistochemical and stereological analysis. J Anat. 2014;225:463–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Gao Z, Ye Y, Zhang W, Shen D, Zhong Y, Jiang K, et al. An anatomical, histopathological, and molecular biological function study of the fascias posterior to the interperitoneal colon and its associated mesocolon: their relevance to colonic surgery. J Anat. 2013;223:123–32.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Munkedal DL, Laurberg S, Hagemann-Madsen R, Stribolt KJ, Krag SR, Quirke P, et al. Significant individual variation between pathologists in the evaluation of colon cancer specimens after complete mesocolic excision. Dis Colon Rectum. 2016;59:953–61.

    Article  PubMed  Google Scholar 

  13. Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal carcinoma, 2nd ed. (English). Tokyo: Kanehara; 2009.

    Google Scholar 

  14. Kawada H, Kurita N, Nakamura F, Kawamura J, Hasegawa S, Kotake K, et al. Incorporation of apical lymph node status into the seventh edition of the TNM classification improves prediction of prognosis in stage III colonic cancer. Br J Surg. 2014;101:1143–52.

    Article  CAS  PubMed  Google Scholar 

  15. Kotake K, Mizuguchi T, Moritani K, Wada O, Ozawa H, Oki I, et al. Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer. Int J Color Dis. 2014;29:847–52.

    Article  Google Scholar 

  16. Lu JY, Xu L, Xue HD, Zhou WX, Xu T, Qiu HZ, et al. The radical extent of lymphadenectomy - D2 dissection versus complete mesocolic excision of laparoscopic right colectomy for right-sided colon cancer (RELARC) trial: study protocol for a randomized controlled trial. Trials. 2016;17:582.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Hernanz F, Revuelta S, Redondo C, Madrazo C, Castillo J, Gómez-Fleitas M. Colorectal adenocarcinoma: quality of the assessment of lymph node metastases. Dis Colon Rectum. 1994;37:373–6.

    Article  CAS  PubMed  Google Scholar 

  18. Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC. For patients with Dukes’ B (TNM stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer. 1998;83:666–72.

    Article  CAS  PubMed  Google Scholar 

  19. Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22:3408–19.

    Article  PubMed  Google Scholar 

  20. Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, et al. ESMO consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol. 2012;23:2479–516.

    Article  CAS  PubMed  Google Scholar 

  21. Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005;23:8706–12.

    Article  PubMed  Google Scholar 

  22. Hoshino N, Hasegawa S, Hida K, Kawada K, Sugihara K, Sakai Y. Impact of age on the prognostic value of number of lymph nodes retrieved in patients with stage II colorectal cancer. Int J Color Dis. 2016;31:1307–13.

    Article  Google Scholar 

  23. Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol. 2010;28:264–71.

    Article  PubMed  Google Scholar 

  24. Lan YT, Yang SH, Chang SC, Liang WY, Li AF, Wang HS, et al. Analysis of the seventh edition of American Joint Committee on colon cancer staging. Int J Color Dis. 2012;27:657–63.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nobuaki Hoshino .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hoshino, N., Hida, K., Sakurai, T., Sakai, Y. (2018). Pathologic Assessment and Specimen Quality of Surgery After CME. In: Kim, N., Sugihara, K., Liang, JT. (eds) Surgical Treatment of Colorectal Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-10-5143-2_25

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-5143-2_25

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-5142-5

  • Online ISBN: 978-981-10-5143-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics